QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 whats-going-on-with-longeveron-stock

Longeveron shares are trading higher Thursday, and the stock is up more than 200% this week. Here's a look at what's go...

 longeveron-shares-resume-trade
Longeveron Shares Resume Trade
06/13/2024 14:13:05

Core News & Articles
Market-Moving News for June 13th
06/13/2024 12:28:13

TSLA: 7% | Tesla Bull Gary Black Sees Elon Musk's $56B Pay Package Pass 'Easily' At Shareholder Meeting; Expects St...

 why-are-longeveron-shares-trading-higher-wednesday

Longeveron Inc. (NASDAQ: LGVN) shares are moving higher on Wednesday afternoon following the circulation of a Zacks Small Cap R...

 watching-longeveron-zacks-small-cap-research-issues-1510-price-valuation-says-longeveron-is-focusing-on-using-its-primary-treatment-lomecel-b-to-fight-a-rare-pediatric-heart-birth-defect-that-devastates-families-announced-the-completion-of-an-encouraging-meeting-with-investigators-involved-in-the-ongoing-trial-of-lomecel-b-for-the-treatment-of-hlhs

https://scr.zacks.com/files/News/2024/Zacks_SCR_Research_06122024_LGVN_Sorensen.pdf

 longeveron-completes-successful-investigator-meeting-for-on-going-phase-2b-clinical-trial-evaluating-lomecel-b-as-potential-treatment-for-hlhs-rare-pediatric-cardiac-disease

Longeveron® Announces Completion of Successful Investigator Meeting for On-going Phase 2b Clinical Trial Evaluating Lomecel-B™ ...